KRAS and cholangiocarcinoma: KRAS mutations are relatively common in CCA, with a reported frequency of 24–27% in iCCA [49,50] and 37–46% in eCCA [48,49,51,52], suggesting a slight tendency toward higher prevalence in eCCA.